Evidence map›Paper›PMID 39574088›Full record

SynthesisBMC cancer2024

Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.

Hebatalla Abdelmaksoud Abdelmonsef Ahmed, Mohammed Hamdi Abbas, Hussein Awad Hussein, Rehab Salah Fathy Nasr, Amira Ahmed Lashen, Heba Khaled, Ahmed Azzam

Erratum issuedAbstract readSystematic ReviewMeta-Analysis
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in BMC cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Hebatalla Abdelmaksoud Abdelmonsef AhmedPublic Health & Community Medicine, Faculty of Medicine, Kafr-Elsheikh University, Kafr-Elsheikh, Egypt. Heba_Abdelmasoud@med.kfs.edu.eg.ORCID http://orcid.org/0000-0002-1882-6623
Mohammed Hamdi AbbasFaculty of Medicine, Tanta University, Tanta, Egypt.
Hussein Awad HusseinFaculty of Medicine, Tanta University, Tanta, Egypt.
Rehab Salah Fathy NasrFaculty of Medicine, Benha University, Benha, Egypt.
Amira Ahmed LashenFaculty of Pharmacy, Tanta University, Tanta, Egypt.
Heba KhaledDepartment of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Ahmed AzzamDepartment of Microbiology and Immunology, Faculty of Pharmacy, Helwan University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCervical cancer, though one of the most common cancers affecting women globally, holds immense potential for prevention through screening. Therefore, we conducted this meta-analysis to assess the rate of cervical cancer screening in Arab countries and identify barriers among those who did not participate.

methodsA comprehensive search was conducted from January 1st to June 1st,2024, including all observational studies that reported cervical cancer screening uptake in any Arab country. A meta-analysis was performed using a random-effects model to estimate the pooled prevalence, and sensitivity analyses were conducted to test the robustness of the findings. The study followed PRISMA guidelines.

resultsThis meta-analysis, covering 55 studies and 204,940 Arab women, found an overall cervical cancer screening uptake rate of 18.2% (95% CI: 13.9-23.6), with sensitivity analysis confirming the reliability of this estimate. Country disparities were evident, with Bahrain having the highest uptake at 44.1%, while Somalia had the lowest at 8.9%. Among women who underwent screening, the majority were ever-married (94.7%) and held positive attitudes towards screening (91.0%). Barriers to screening were common among women who did not participate, with the most frequent reasons being a lack of information (25.1%), the misconception of feeling healthy (24.5%), fear of the procedure (19.3%), and feelings of embarrassment (13.2%). Additionally, women who were screened had lower perceived barrier scores (SMD = -0.466) and higher perceived benefits scores (SMD = 0.379) than those who were not (p < 0.05).

conclusionThis meta-analysis reveals a low overall cervical cancer screening uptake (18.2%) among Arab women. Key barriers such as lack of information, fear, the misconception of feeling healthy, and embarrassment hinder uptake. This alarmingly low rate underscores the urgent need for targeted interventions to address these barriers and promote awareness of early detection's life-saving potential.

Indexed as

Early Detection of CancerUterine Cervical NeoplasmsAdultArabsFemaleHealth Knowledge, Attitudes, PracticeHumansMass ScreeningMiddle EastPatient Acceptance of Health CareArab countriesCervical cancer uptakeMeta-analysis

Identifiers

PMID39574088
PMCPMC11583763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.